Trastuzumab emtansine plus atezolizumab versus trastuzumab emtansine plus placebo in previously treated, HER2-positive advanced breast cancer (KATE2): a phase 2, multicentre, randomised, double-blind trial
| Autor: | Emens, Leisha A *, Esteva, Francisco J, Beresford, Mark, Saura, Cristina, De Laurentiis, Michelino, Kim, Sung-Bae, Im, Seock-Ah, Wang, Yifan, Salgado, Roberto, Mani, Aruna, Shah, Jigna, Lambertini, Chiara, Liu, Haiying, de Haas, Sanne L, Patre, Monika, Loi, Sherene |
|---|---|
| Zdroj: | In The Lancet Oncology October 2020 21(10):1283-1295 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|